Butcher Arthur C's Form 4 filing
Boston Scientific Corp (BSX) · filed Feb 6, 2023
- Accession no.
- 0001225208-23-001356
- Filed
- Feb 6, 2023
- Trade date
- Feb 3, 2023
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.32M. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Butcher Arthur CCIK 0001678249 | Officer (EVP& Grp Pres, MedSurg & APAC) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 3, 2023 | Common Stock | MOption exerciseAcquired | +10,822 | $16.31 | +$176,506.82 | 46,180 | Direct | |
| Feb 3, 2023 | Common Stock | MOption exerciseAcquired | +4,212 | $17.26 | +$72,699.12 | 50,392 | Direct | |
| Feb 3, 2023 | Common Stock | SSaleDisposed | −27,000 | $48.74F1 | −$1,315,980 | 23,392 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 3, 2023 | Common Stock | MOption exerciseDisposed | −4,212 | $0.00 | $0 | 11,931 | Direct | |
| Feb 3, 2023 | Common Stock | MOption exerciseDisposed | −10,822 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $48.70 to $48.78, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.